BrainStorm, Octane Medical Group deal

The companies partnered to co-develop a proprietary bioreactor to produce BrainStorm's NurOwn NTF

Read the full 132 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE